Why is this beneficial?


All numbers in millions of US Dollars
2013 (01/31/14) 2012 (01/31/13) 2011 (01/31/12) 2010 (01/31/11) 2009 (01/31/10)

Current Assets

Log in for more information
Cash and Short-Term Investments – Total 204 237 322
Receivables – Total 978 899 947
Inventories – Total 0 0 0
Current Assets – Other – Total 163 176 153
Current Assets Total
1,346 1,312 1,422

Non-Current Assets

Property Plant and Equipment – Total (Net) 222 243 216
Investment and Advances – Equity 1 1 1
Investment and Advances – Other 0 0 0
Intangible Assets – Total 465 458 534
Non-Current Assets – Other – Total 48 60 82
Non–Current Assets Total
736 762 833


2,082 2,074 2,256

Liabilities and Shareholders' Equity

All numbers in millions of US Dollars
2013 (01/31/14) 2012 (01/31/13) 2011 (01/31/12) 2010 (01/31/11) 2009 (01/31/10)


Log in for more information

Current Liabilities

Debt in Current Liabilities 284 97 113
Account Payable/Creditors – Trade 562 593 650
Income Taxes Payable 18 8 13
Current Liabilities – Other 196 197 211
Current Liabilities Total
1,060 895 986

Long–Term Liabilities

Long-Term Debt Total 267 278 247
Deferred Taxes and Investment Tax Credit 14 30 32
Liabilities (Other) 38 47 39
Long-Term Liabilities Total
319 355 318
Liabilities Total
1,379 1,250 1,304
Minority Interest – Balance Sheet
0 0 0

Shareholders' Equity

Preferred/Preference Stock (Capital) – Total 0 0 0
Common/Ordinary Equity – Total 688 810 939
Shareholders' Equity Total
688 810 939


2,082 2,074 2,256
PDFs require Adobe®Reader® and will open in a new window.
  • S&P Capital IQ® Company Report (PDF)
    S&P Capital IQ® – 03/30/15

    Historical data on financials with interactive charts, technical indicators, and five-year peer comparison trends charts

  • Audit Integrity Company Report (PDF)
    Audit Integrity – 08/06/14

    Forensic analysis of financial reporting and governance practices to identify, measure, and monitor potential associated risks.

Why is Data Standardization Beneficial?

Companies often present their financial results in a variety of formats, making it difficult to construct parallel company comparisons on an "apples-to-apples" basis. After collecting data from a diverse set of sources, S&P Capital IQ standardizes it by financial statement and by specific data item definition, preparing information so that it is comparable across companies, industries and time periods.

More about data standardization from S&P Capital IQ (PDF)
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.

Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.